| Application no. and date | 15706185.4 (espacenet) (Federated) (European Patent Register), 20150213 | | Patent/reg. no. and date | DK/EP 3105220, 20200701 | | Publication date | 20161221 | | Priority no. and date | EP 14155137, 20140214 | | EP pub. no. and date |
EP 3105220 20161221 | | Effective date | | | Applicant/owner | Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91
4123 Allschwil, CH | | Applicant ref. no. | P73987DK01 | | Inventor | ABELE, Stefan, c/o Actelion Pharmaceuticals Ltd.
Gewerbestrasse 16
CH-4123 Allschwil, CH,
FUNEL, Jacques-Alexis, c/o Actelion Pharmaceuticals Ltd.
Gewerbestrasse 16
CH-4123 Allschwil, CH,
SCHINDELHOLZ, Ivan, c/o Actelion Pharmaceuticals Ltd.
Gewerbestrasse 16
CH-4123 Allschwil, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07D 401/12 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF PYRIMIDINSULFAMIDDERIVATER | | Int. application no. | EP2015053047 | | Int. publication no. | WO2015121397 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
